| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 39 |
| 1 | PEMBROLIZUMAB | 39 |
| 2 | PACLITAXEL | 31 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 29 |
| 4 | DOSTARLIMAB | 23 |
| 5 | DURVALUMAB | 22 |
| 6 | ACETAMINOPHEN | 11 |
| 7 | ONDANSETRON HYDROCHLORIDE | 11 |
| 8 | NIVOLUMAB | 10 |
| 9 | ACETAMINOPHEN 500MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOSTARLIMAB | 23 | 0.0092 |
| 1 | TREMELIMUMAB | 9 | 0.0020 |
| 2 | ELRANATAMAB-BCMM | 2 | 0.0017 |
| 3 | DURVALUMAB | 22 | 0.0010 |
| 4 | ENFORTUMAB VEDOTIN | 6 | 0.0008 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | FOSAPREPITANT DIMEGLUMINE | 7 | 0.0005 |
| 7 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 9 | PEMBROLIZUMAB | 39 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 22 | 0.0010 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 77 | 0.0008 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 14 | 0.0003 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 34 | 0.0002 |
| 5 | Platinum-based Drug [EPC] | 43 | 0.0002 |
| 6 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 7 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 11 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |